Analysis of the Short-term Efficacy and Safety of Pembrolizumab Combined with Carboplatin and Paclitaxel in the Treatment of Advanced or Recurrent Endometrial Cancer

FAN Atong

doi:10.3969/j.issn.1672-7185.2021.09.023

Home>Articles>Analysis of the Short-term Efficacy and Safety of Pembrolizumab Combined with Carboplatin and Paclitaxel in the Treatment of Advanced or Recurrent Endometrial Cancer

DOI: 10.3969/j.issn.1672-7185.2021.09.023

Analysis of the Short-term Efficacy and Safety of Pembrolizumab Combined with Carboplatin and Paclitaxel in the Treatment of Advanced or Recurrent Endometrial Cancer

FAN Atong

Machine-generated Keywords：

Publication Date：2021-09-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：3( 69-71 )

Chinese Practical Journal of Rural Doctor

ISSN：1672-7185

Year, Vol.(Issue)：2021,28(9)